Eli Lilly Stock Target Price and Analyst Consensus

LLY Stock  USD 724.87  7.33  1.00%   
The current analyst and expert consensus on Eli Lilly is Strong Buy with 6 hold recommendations. The current projected Eli Lilly target price consensus is 603.57 with 28 analyst opinions. One of the most common ways Eli Lilly analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Eli Lilly vendors, executives, and/or customers. Eli Lilly recommendation module provides expert sentiment on the projected Eli Lilly target price to derive its highest and lowest estimates based on target price standard deviation of 0.0. Check out Macroaxis Advice on Eli Lilly to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
Lowest Forecast
549.25
Highest Forecast
669.96
Target Price
603.57
At this time, Eli Lilly's Gross Profit is fairly stable compared to the past year. Pretax Profit Margin is likely to rise to 0.25 in 2024, whereas Operating Profit Margin is likely to drop 0.28 in 2024. At this time, Eli Lilly's Inventory is fairly stable compared to the past year. Total Liabilities is likely to rise to about 55.8 B in 2024, whereas Total Stockholder Equity is likely to drop slightly above 9 B in 2024.
  
It's important to approach Eli Lilly's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Eli Lilly price targets

Eli Lilly's stock target price is an estimate of its future price, usually made by analysts. Using Eli Lilly's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Eli Lilly's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Eli Lilly's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Eli Lilly Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Eli Lilly is a key component of Eli Lilly valuation and have some predictive power on the future returns of a Eli Lilly.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Eli Lilly's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
722.43724.14725.85
Details
Intrinsic
Valuation
LowRealHigh
686.05687.76797.36
Details
Earnings
Estimates (0)
LowProjected EPSHigh
2.222.462.78
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Eli Lilly. Your research has to be compared to or analyzed against Eli Lilly's peers to derive any actionable benefits. When done correctly, Eli Lilly's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Eli Lilly.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Hedge Favorites Idea
Hedge Favorites
Invested over 100 shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 60 shares
Business Services Idea
Business Services
Invested few shares
Momentum Idea
Momentum
Invested over 40 shares
FinTech Idea
FinTech
Invested over 40 shares
Macroaxis Picks Idea
Macroaxis Picks
Invested over 40 shares
When determining whether Eli Lilly offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eli Lilly's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eli Lilly And Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eli Lilly And Stock:
Check out Macroaxis Advice on Eli Lilly to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Complementary Tools for Eli Stock analysis

When running Eli Lilly's price analysis, check to measure Eli Lilly's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Eli Lilly is operating at the current time. Most of Eli Lilly's value examination focuses on studying past and present price action to predict the probability of Eli Lilly's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Eli Lilly's price. Additionally, you may evaluate how the addition of Eli Lilly to your portfolios can decrease your overall portfolio volatility.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
The data published in Eli Lilly's official financial statements usually reflect Eli Lilly's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Eli Lilly. For example, before you start analyzing numbers published by Eli accountants, it's critical to develop an understanding of what Eli Lilly's liquidity, profitability, and earnings quality are in the context of the Pharmaceuticals space in which it operates.
Please note, the presentation of Eli Lilly's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Eli Lilly's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Eli Lilly's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Eli Lilly and. Please utilize our Beneish M Score to check the likelihood of Eli Lilly's management manipulating its earnings.